News & Announcements

Three Weil Partners Named Washington, D.C. Trailblazers in 2020 by The National Law Journal

Joseph Pari, John Scribner, Steven Tyrrell

Three Weil partners have been named “Washington, D.C. Trailblazers” by The National Law Journal. The inaugural report recognizes 50 attorneys in the nation’s capital who are “innovators and thought leaders” in their respective practice areas.

Weil’s three honorees, the most of any firm, highlight Weil’s extensive expertise across its Antitrust, Tax and White Collar Defense practices. The honorees were profiled in a special “Washington, D.C. Trailblazers” supplement published today by NLJ.

  • Tax Department Co-Chair Joseph Pari was recognized as a leading tax lawyer specializing in complex merger and acquisition transactions, financings and restructurings. The profile noted the breadth of Mr. Pari’s tax expertise as well as his strengths as a deal lawyer. His recent highlights include advising PG&E in its landmark chapter 11 restructuring, Willis Towers Watson PLC in its proposed $80 billion combination with Aon PLC, and Dow’s $40 billion spinoff from DowDuPont into three separate publicly traded companies, among other matters.
  • Antitrust partner John Scribner was recognized for his success guiding major mergers through antitrust review at the U.S. Federal Trade Commission and Department of Justice. The profile highlighted Mr. Scribner’s particular experience in the pharmaceutical industry, noting that he has recently secured antitrust approval for Abbott Laboratories’ $5.3 billion acquisition of Alere and for Sanofi in a suite of cutting-edge transactions, including the $25 billion exchange of Sanofi’s animal health business with the consumer healthcare business of Boehringer Ingelheim.
  • White Collar Defense, Regulatory and Investigations practice Co-Head Steven Tyrrell was recognized as one of the foremost experts on corporate crime and an accomplished trial attorney. The profile noted Mr. Tyrrell’s record of success in defending large corporate clients in high-profile investigations, including Sanofi, Vantage Drilling, Innodata Inc. and HMT LLC. In addition to securing numerous declinations from the U.S. Department of Justice, Mr. Tyrrell’s accomplishments as a trailblazer include serving as lead trial counsel in one of the first white-collar criminal trials arising out of the opioid epidemic. Formerly the Chief of the U.S. Department of Justice’s Fraud Section, Mr. Tyrrell oversaw more than 50 corporate prosecutions and developed leading-edge expertise on the Foreign Corrupt Practices Act, the NLJ noted.